Affinity DataKi: 6.20nMAssay Description:Binding affinity(KI) for formation of reversible enzyme-ligand complex with human placental aromatase (PL2)More data for this Ligand-Target Pair
Affinity DataKi: 28nMAssay Description:Binding affinity(KI) for formation of reversible enzyme-ligand complex with human placental aromatase (PL2)More data for this Ligand-Target Pair
Affinity DataKi: 47nMAssay Description:Binding affinity for formation of reversible enzyme-ligand complexes with human placental aromatase (PL2)More data for this Ligand-Target Pair
Affinity DataKi: 100nMAssay Description:Binding affinity(KI) for formation of reversible enzyme-ligand complex with human placental aromatase (PL2)More data for this Ligand-Target Pair
Affinity DataKi: 542nMAssay Description:Binding affinity(KI) for formation of reversible enzyme-ligand complex with human placental aromatase (PL2)More data for this Ligand-Target Pair
Affinity DataKi: 3.10E+3nMAssay Description:Binding affinity(KI) for formation of reversible enzyme-ligand complex with human placental aromatase (PL2)More data for this Ligand-Target Pair
Affinity DataKi: 3.76E+4nMAssay Description:Inhibition of human recombinant CYP3A5 using testosterone as substrate assessed as testosterone 6-beta-hydroxylation preincubated up to 30 mins with ...More data for this Ligand-Target Pair
Affinity DataKi: 9.50E+6nMAssay Description:Inhibition of human CYP2E1 assessed as chlorzoxazone 6-hydroxylase activity by HPLC analysisMore data for this Ligand-Target Pair